Loading page content...
Back to All Products
Gastroenterology View All Products
ESOSTART-DSR
A Leadwell Pharmaceuticals Brand
Advanced acid suppression and gastrointestinal motility support for effective management of acid-related disorders.
Marketed by Leadwell Pharmaceuticals
ESOSTART-DSR is a combination of Esomeprazole Enteric Coated 40 mg and Domperidone Sustained Release 30 mg formulated for the management of acid-related gastrointestinal disorders.
Dosage Form
Capsules
Category
Gastroenterology
Product Overview
About ESOSTART-DSR
ESOSTART-DSR combines the proton pump inhibitor Esomeprazole with the prokinetic agent Domperidone to provide effective gastric acid suppression while improving gastrointestinal motility. It is formulated to help relieve symptoms of gastroesophageal reflux disease (GERD), gastritis, dyspepsia and NSAID-induced gastric ulcers.
Formula
Composition
IngredientQuantity
Esomeprazole (EC)40 mg
Domperidone (SR)30 mg
Ingredient Profile
Key Ingredients
Esomeprazole
A proton pump inhibitor that suppresses gastric acid secretion and promotes healing of acid-related disorders.
Domperidone
A prokinetic agent that improves gastric emptying and helps relieve nausea, bloating and reflux symptoms.
Product Highlights
Why This Formulation
Advanced gastric acid suppression
Supports relief from heartburn and acid reflux
Helps improve gastric motility
Effective in NSAID-induced gastric ulcers
Supports healing in GERD and gastritis
Combination of proton pump inhibitor and prokinetic therapy
Product Information
Used in the management of Gastroesophageal Reflux Disease (GERD), NSAID-induced ulcers, non-ulcer dyspepsia and gastritis, as directed by a registered healthcare professional.
Directions for Use
Use only as directed by a registered healthcare professional.
Storage
Store in a cool and dry place, protected from direct sunlight and moisture. Keep out of reach of children.
For the use of a registered medical practitioner, hospital or laboratory only. This information is intended for healthcare professionals and educational purposes. It is not a substitute for medical advice, diagnosis or treatment.
Explore More
Related Products
Gastroenterology
ESOSTART-40
ESOSTART-40 contains Esomeprazole 40 mg, a proton pump inhibitor formulated to provide effective gastric acid suppression for the management of acid-related disorders.
View ProductGastroenterology
DEXLEAD-DSR
DEXLEAD-DSR is a prescription gastrointestinal formulation combining Dexrabeprazole Modified Release with Domperidone Sustained Release to support acid suppression and gastric motility in patients with acid-related disorders.
View Product